Crucial pathophysiological role of CXCR2 in experimental ulcerative colitis in mice

Journal of Leukocyte Biology

Volumn 82, Issue 5, 2007, Pages 1239-1246

  Buanne, Pasquale ^a   Di Carlo, Emma ^b   Caputi, Lorenzo ^a   Brandolini, Laura ^a   Mosca, Marco ^a   Cattani, Franca ^a   Pellegrini, Luigi ^a   Biordi, Leda ^c   Coletti, Gino ^d   Sorrentino, Carlo ^b   Fedele, Guido ^f   Colotta, Francesco ^a,e   Melillo, Gabriella ^a   Bertini, Riccardo ^a  

^a Dompépharma Spa ^*  (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

^d Operative Unit of Pathological Anatomy   (Italy)

^e Biometry and Clinical Epidemiology Unit   (Italy)

^f NERVIANO MEDICAL SCIENCES   (Italy)

Author keywords

Inflammation; Neutrophils; Rodent

Indexed keywords

CHEMOKINE RECEPTOR CXCR2; CXCL1 CHEMOKINE; DEXTRAN SULFATE; DRINKING WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON MUCOSA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE TIME EFFECT RELATION; ENZYME ACTIVATION; ENZYME ACTIVITY; EXPERIMENTAL MODEL; HISTOPATHOLOGY; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; RECURRENT DISEASE; SYMPTOM; TISSUE INJURY; ULCERATIVE COLITIS; WILD TYPE;

ANIMALS; CHEMOKINE CXCL1; CHEMOKINE CXCL2; CHRONIC DISEASE; COLITIS, ULCERATIVE; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; FLUORESCENT ANTIBODY TECHNIQUE; INCIDENCE; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NEUTROPHILS; PEROXIDASE; RECEPTORS, INTERLEUKIN-8B;

MUS; RODENTIA;

EID: 36248954497     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0207118     Document Type: Article

References (45)

1. Ajuebor, M. N., Swain, M. G. (2002) Role of chemokines and chemokine receptors in the gastrointestinal tract. Immunology 105, 137-143.
2. Podolsky, D. K. (2002) Inflammatory bowel disease. N. Engl. J. Med. 347, 417-429.
3. Palmen, M. J., Dijkstra, C. D., van der Ende, M. B., Pena, A. S., van Rees, E. P. (1995) Anti-CD11b/CD18 antibodies reduce inflammation in acute colitis in rats. Clin. Exp. Immunol. 101, 351-356.
4. Natsui, M., Kawasaki, K., Takizawa, H., Hayashi, S. I., Matsuda, Y., Sugimura, K., Seki, K., Narisawa, R., Sendo, F., Asakura, H. (1997) Selective depletion of neutrophils by a monoclonal antibody, RP-3, suppresses dextran sulphate sodium-induced colitis in rats. J. Gastroenterol. Hepatol. 12, 801-808.
5. Mazzucchelli, L., Hauser, C., Zgraggen, K., Wagner, H., Hess, M., Laissue, J. A., Mueller, C. (1994) Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation. Am. J. Pathol. 144, 997-1007.
6. Uguccioni, M., Gionchetti, P., Robbiani, D. F., Rizzello, F., Peruzzo, S., Campieri, M., Baggiolini, M. (1999) Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis. Am. J. Pathol. 155, 331-336.
7. Fan, X., Patera, A. C., Pong-Kennedy, A., Deno, G., Gonsiorek, W., Mandra, J. D., Vassileva, G., Zeng, A., Jackson, C., et al. (2006) Murine CXCR1 is a functional receptor for GCP-2/CXCL6 and IL-8/ CXCL8. J. Biol. Chem., In press.
8. Lee, J., Cacalano, G., Camerato, T., Toy, K., Moore, M. W., Wood, W. I. (1995) Chemokine binding and activities mediated by the mouse IL-8 receptor. J. Immunol. 155, 2158-2164.
9. Gerard, C., Rollins, B. J. (2001) Chemokine and disease. Nat. Immunol. 2, 108-115.
10. Keshavarzian, A., Fusunyan, R. D., Jacyno, M., Winship, D., MacDermott, R. P., Sanderson, I. R. (1999) Increased interleukin-8 (IL-8) in rectal dialysate from patients with ulcerative colitis: evidence for a biological role for IL-8 in inflammation of the colon. Am. J. Gastroenterol. 94, 704-712.
11. Banks, C., Bateman, A., Payne, R., Johnson, P., Sheron, N. (2003) Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. J. Pathol. 199, 28-35.
12. Katsuta, T., Lim, C., Shimoda, K., Shibuta, K., Mitra, P., Banner, B. F., Mori, M., Bernard, G. F. (2000) Interleukin-8 and SDF1-alpha mRNA expression in colonic biopsies from patients with inflammatory bowel disease. Am. J. Gastroenterol. 95, 3157-3164.
13. McCormack, G., Moriarty, D., O'Donoghue, D. P., McCormick, P. A., Sheahan, K., Baird, A. W. (2001) Tissue cytokine and chemokine expression in inflammatory bowel disease. Inflamm. Res. 50, 491-495.
14. Daig, R., Andus, T., Aschenbrenner, E., Falk, W., Schölmerich, J., Gross, V. (1996) Increased interleukin-8 expression in the colon mucosa of patients with inflammatory bowel disease. Gut 38, 216-222.
15. Izzo, R. S., Witkon, K., Chen, A. I., Hadjiyane, C., Weinstein, M. I., Pellecchia, C. (1992) Interleukin-8 and neutrophils markers in colonic mucosa from patients with ulcerative colitis. Am. J. Gastroenterol. 87, 1447-1452.
16. Mitsuyama, K., Toyonaga, A., Sasaki, E., Watanabe, K., Tateishi, H., Nishiyama, T., Saiki, T., Ikeda, H., Tsuruta, O., Tanikawa, K. (1994) IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn's disease. Clin. Exp. Immunol. 96, 432-436.
17. Cooper, H. S., Murphy, S. N., Shah, R. S., Sedergran, D. J. (1993) Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Invest. 69, 238-249.
18. Cacalano, G., Lee, J., Kikly, K., Ryan, A. M., Pitts-Meek, S., Hultgren, B., Wood, W. I., Moore, M. W. (1994) Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. Science 265, 682-684.
19. Del Rio, L., Bennouna, S., Salinas, J., Denkers, E. Y. (2001) CXCR2 deficiency confers impaired neutrophil recruitment and increased susceptibility during Toxoplasma gondii infection. J. Immunol. 167, 6503-6509.
20. Myers, K. J., Murthy, S., Flanigan, A., Witchell, D. R., Butler, M., Murray, S., Siwkowski, A., Goodfellow, D., Madsen, K., Baker, B. (2003) Antisense oligonucleotide blockade of tumor necrosis factor-alpha in two murine models of colitis. J. Pharmacol. Exp. Ther. 304, 411-424.
21. Murthy, S., Flanigan, A., Coppola, D., Buelow, R. (2002) RDP58, a locally active TNF-α inhibitor, is effective in the dextran sulphate mouse model of chronic colitis. Inflamm. Res. 51, 522-531.
22. Okayasu, I., Hatakeyama, S., Yamada, M., Ohkusa, T., Inagaki, Y., Nakaya, R. (1990) A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98, 694-702.
23. Geboes, K., Riddell, R., Öst, A., Jensfelt, B., Persson, T., Löfberg, R. (2000) A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut 47, 404-409.
24. Seldenrijk, C. A., Morson, B. C., Meuwissen, S. G., Schipper, N. W., Lindeman, J., Meijer, C. J. (1991) Histopathological evaluation of colonic mucosal biopsy specimens in chronic inflammatory bowel disease: diagnostic implications. Gut 32, 1514-1520.
25. Krawisz, J. E., Sharon, P., Stenson, W. F. (1984) Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 87, 1344-1350.
26. Klebanoff, S. J., Waltersdorph, A. M., Rosen, H. (1984) Antimicrobial activity of myeloperoxidase. In: Methods in Enzymology, Academic Press, New York. NY pp. 399-403.
27. Stokes, M. E., Davis, C. S., Koch, G. G. (1995) Categorical Data Analysis Using the SAS System. SAS Institute Inc., Cary. NC, 449 pp.
28. Wolfinger, R. D. (1997) An example of using mixed models and PROC MIXED for longitudinal data. J. Biopharm. Stat. 7, 481-500.
29. Forbes, E., Murase, T., Yang, M., Matthaei, K. I., Lee, J. J., Lee, N. A., Foster, P. S., Hogan, S. P. (2004) Immunopathogenesis of experimental ulcerative colitis is mediated by eosinophil peroxidase. J. Immunol. 172, 5664-5675.
30. Talbot, I. C., Price, A. B. (1987) Biopsy Pathology in Colorectal Disease. Cambridge University Press, Cambridge, UK.
31. Whitehead, R., Johansen, A., Rubio, C. A. (1995) Gastrointestinal and Oesophageal Pathology. Churchill Livingstone. New York, NY.
32. Murthy, S. N., Cooper, H. S., Shim, H., Shah, R. S., Ibrahim, S. A., Sedergran, D. J. (1993) Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig. Dis. Sci. 38, 1722-1734.
33. Murthy, S., Cooper, H. S., Yoshitake, H., Meyer, C., Meyer, C. J., Murthy, N. S. (1999) Combination therapy of pentoxifilline and TNFalpha monoclonal antibody in dextran sulphate-induced mouse colitis. Aliment. Pharmacol. Ther. 13, 251-260.
34. Baert, F. J., D'Haens, G. R., Peeters, M., Hiele, M. I., Schaible, T. F., Shealy, D., Geboes, K., Rutgeerts, P. J. (1999) Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis. Gastroenterology 116, 22-28.
35. D'haens, G.R., Van Deventer, S., Van Hogezand, R., Chalmers, D., Kothe, C., Baert, F., Braakman, T., Schaible, T., Geboes, K., Rutgeerts, P. (1999) Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial. Gastroenterology 116, 1029-1034.
36. Sandborn, W. J. (2005) New concepts in anti-tumor necrosis factor therapy for inflammatory bowel disease. Rev. Gastroenterol. Disord. 5, 10-18.
37. Hans, W., Schölmerich, J., Gross, V., Falk, W. (2000) Interleukin-12 induced interferon- increases inflammation in acute dextran sulfate sodium induced colitis in mice. Eur. Cytokine Netw. 11, 67-74.
38. Kojouharoff, G., Hans, W., Obermeier, F., Mannel, D. N., Andus, T., Schölmerich, J., Gross, V., Falk, W. (1997) Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice. Clin. Exp. Immunol. 107, 353-358.
39. Woodruff, T. M., Arumugam, T. V., Shiels, I. A., Reid, R. C., Fairlie, D. P., Taylor, S. M. (2003) A potent human C5a receptor antagonist protects against disease pathology in a rat model of inflammatory bowel disease. J. Immunol. 171, 5514-5520.
40. Li, X., Klintman, D., Liu, Q., Sato, T., Jeppsson, B., Thorlacius, H. (2004) Critical role of CXC chemokines in endotoxemic liver injury in mice. J. Leukoc. Biol. 75, 443-452.
41. Zhang, X. W., Liu, Q., Wang, Y., Thorlacius, H. (2001) CXC chemokines, MIP-2 and KC, induce P-selectin-dependent neutrophil rolling and extravascular migration in vivo. Br. J. Pharmacol. 133, 413-421.
42. Godaly, G., Hang, L., Frendéus, B., Svanborg, C. (2000) Transepithelial neutrophil migration is CXCR1 dependent in vitro and is defective in IL-8 receptor knockout mice. J. Immunol. 165, 5287-5294.
43. Smith, M. L., Olson, T. S., Ley, K. (2004) CXCR2 and E-selectin-induced neutrophil arrest during inflammation in vivo. J. Exp. Med. 200, 935-939.
44. Reutershan, J., Morris, M. A., Burcin, T. L., Smith, D. F., Chang, D., Saprito, M. S., Ley, K. (2006) Critical role of endothelial CXCR2 in LPS-induced neutrophil migration into the lung. J. Clin. Invest. 116, 695-702.
45. Williams, E. J., Haque, S., Banks, C., Johnson, P., Sarsfield, P., Sheron, N. (2000) Distribution of the interleukin-8 receptors, CXCR1 and CXCR2, in inflamed gut tissue. J. Pathol. 192, 533-539.